Ilika PLC (AIM: IKA, OTCQX: ILIKF) said it has reached the final stages of commercial readiness for its Stereax solid-state batteries after completing technical validation with Cirtec Medical and process qualification in August, is running production lots and expects to make first customer shipments by year-end barring festive‑period disruption. Its larger-format Goliath programme has progressed in parallel: 2Ah P1 prototypes were validated by customers earlier this year, a government grant in July is funding manufacture of A‑sample automotive cells, collaborations with Jaguar Land Rover and Oxford are underway, and an automated pilot line has scaled prototypes from 2Ah to 10Ah with delivery of these larger prototypes expected by the end of 2025. Management says these operational milestones, rather than near‑term financials, are the key value drivers as product revenue and investor interest should increase through 2026 if commercialization and ramp proceed as planned.
Ilika PLC (AIM: IKA, OTCQX: ILIKF) reported it has reached the final stages of commercial readiness for its Stereax solid‑state batteries after completing technical validation with Cirtec Medical and finalising process qualification in August; the company has been running production lots and expects to complete first customer shipments by year‑end, barring disruption during the US/UK festive period. Management reports quality control activity on production lots and active commercial engagement, signalling the transition from R&D to initial product revenue in 2026 if shipments proceed as planned. The Goliath programme is advancing in parallel: customers validated 2Ah P1 prototypes earlier in the year, a July government grant supports manufacture of A‑sample automotive cells, and collaborations with Jaguar Land Rover and the University of Oxford continue to inform development. Ilika completed an automated pilot line this summer, scaled prototype capacity from 2Ah to 10Ah, and expects delivery/initiation of those larger prototypes to customers by the close of 2025. Operational milestones, not near‑term financials, are the principal near‑term value drivers; the company expects product revenue next year and greater investor attention as ramping begins. Key execution risks are year‑end shipment timing, QC/customer acceptance of initial lots, and validation of 10Ah Goliath prototypes—all of which will determine whether the current moderately positive sentiment translates into material market impact.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
moderately positive
Sentiment Score
0.55
